Posts by Jeffrey S. Schweitzer, MD, PhD
-
Essential Tremor Treatment Advancements Using MRI-guided Focused Ultrasound: Q&A With Jeffrey S. Schweitzer, MD, PhD
Jeffrey S. Schweitzer, MD, PhD, a neurosurgeon at Massachusetts Hospital, specializing in treating epilepsy, essential tremor, and tremor-dominant Parkinson's diseases. In this Q&A, Dr. Schweitzer discusses the physiological processes underlying essential tremor and the advancements.
-
Co-transplantation of Regulatory T Cells Improves Cell Replacement Therapy for Parkinson's Disease
Research at Massachusetts General Hospital suggests a novel strategy for enhancing the efficacy and safety of cell replacement therapy in the nervous system: co-transplantation of dopamine progenitor cells with regulatory T cells to modulate the host immune response triggered by needle trauma.
-
Patient-derived Dopamine Neurons Show Promise in Parkinson's Treatment
Massachusetts General Hospital and McClean Hospital researchers take significant steps towards proving the safety and efficacy of dopaminergic neuron implantation to treat Parkinson's disease.
-
Collaboration in Developing New Cell Therapy
In this video, Bob S. Carter, MD, PhD, Kwang-Soo Kim, PhD, Todd M. Herrington, MD, PhD, and Jeffrey S. Schweitzer, MD, PhD, discuss their cross-disciplinary and multi-institutional collaboration to develop this new therapy.
-
First-In-Human Therapy with Stem Cell–derived Dopaminergic Progenitor Cells for Parkinson's Disease
Mass General researchers report substantial clinical improvement in a patient with Parkinson's disease after they implanted midbrain dopaminergic progenitor cells that they differentiated in vitro from autologous induced pluripotent stem cells.
-
Novel Implantation Technique May Enhance Outcomes of Intracerebral Cell Therapy
Intracerebral "columnar injection" of stem cells, in which the track created by the surgical cannula is the site of cell deposition, may lead to more efficient cell transplantation and better functional outcomes in Parkinson's disease.
-
Using Stem Cells to Treat Movement Disorders
In this video, Jeffrey Schweitzer, MD, PhD, discusses his research using stem cell technology to restore normal function in patients with movement disorders. He believes this technology may be able to improve outcomes for patients with tremor, Parkinson's disease and dystonia.
-
The Mass General Neurosurgery Mission
Researchers from the Department of Neurosurgery at Massachusetts General Hospital discuss their collaborative work in clinical and translational research.
-
Advances in Treatments for Movement Disorders
Two Mass General neurosurgeons give prominent examples of the hospital’s expertise in functional neurosurgery.
Biography
As a board-certified neurosurgeon, Dr. Schweitzer is passionate about improving and restoring quality of life, especially for patients with Parkinson’s, epilepsy and other movement disorders.
Dr. Schweitzer has over 30 years of experience in the field. Previously, he was the Chief of Neurosurgery at Wright State University-Premier Health Partners and he ran the Epilepsy, Movement Disorder and Pituitary Surgery Programs at Kaiser Permanente Los Angeles Medical Center for 13 years.
He has also served as the Director of the Epilepsy and Functional Neurosurgery at Miami Valley Hospital in Dayton, OH. Most recently, he worked at Scripps Memorial Hospital in San Diego where he was named a top doctor by the San Diego County Medical Society.
In addition to surgery for movement disorders, Dr. Schweitzer is experienced in many areas of surgery of the brain and spine as well as radiosurgery.
Dr. Schweitzer has done extensive research on Parkinson's disease, and he speaks three languages: English, French and Mandarin Chinese.
Neuroscience Care at Mass General
Through a combination of unmatched expertise, creativity and compassion, Mass General Neuroscience relentlessly advances the fields of Neurosurgery, Neurology and Psychiatry to unleash our patients’ potential.